يعرض 341 - 360 نتائج من 21,342 نتيجة بحث عن '(( significant ((largest decrease) OR (larger decrease)) ) OR ( significant decrease decrease ))', وقت الاستعلام: 0.36s تنقيح النتائج
  1. 341
  2. 342

    Test results under the UNLCSL path. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  3. 343
  4. 344

    Test scheme. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  5. 345
  6. 346
  7. 347

    Cohesion correction coefficient. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  8. 348

    Fig 18 in each curve fitting results. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  9. 349

    Fig 29 in each curve fitting results. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  10. 350
  11. 351

    Specimen packaging process. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  12. 352
  13. 353
  14. 354
  15. 355

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  16. 356
  17. 357
  18. 358

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  19. 359

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  20. 360